HIV, VIRAL HEPATITIS AND TUBERCULOSIS PREVENTION - EU CONTRIBUTION TO - EVENT GUIDE - European Commission

Page created by Jeanette Walsh
 
CONTINUE READING
HIV, VIRAL HEPATITIS AND TUBERCULOSIS PREVENTION - EU CONTRIBUTION TO - EVENT GUIDE - European Commission
EU CONTRIBUTION TO
 HIV, VIRAL HEPATITIS AND
TUBERCULOSIS PREVENTION
 AND INTEGRATED RESPONSE
                           AIDS 2018
23-27 JULY 2018 • AMSTERDAM • THE NETHERLANDS

                                                          EVENT GUIDE

                                   Consumers, Health,
                                   Agriculture and Food
                                   Executive Agency
2

    SYMPOSIUM OVERVIEW
    AIDS 2018 CONFERENCE FROM 23 UNTIL 27 JULY 2018 IN AMSTERDAM,
    INCLUDING PRE-EVENTS (STI AND TB 2018)
    SATELLITE SESSIONS TITLES ORGANISERS                           21 JULY     22 JULY         23 JULY         24 JULY         25 JULY

    STI 2018: Understanding       International Association of
    and addressing the            Providers of AIDS Care (IAPAC)
    HIV and STI syndemic
    pre‑conference:                                                All day      All day
    • Sialon II project poster,
       by Massimo Mirandola,
       Verona University Hospital
       - CRESP (IT)
    TB 2018: Bridging the TB      International AIDS Society
    and HIV communities           (IAS), GGD Amsterdam
    pre-conference:               and RIVM
    • E-DETECT TB project                                                      All day
       poster, by Gerard Devries,
       KNCV (NL)
    • TB coalition: Aaron Oxley,
       and Timur Abdullaev
    Welcome reception              Mayor and Alderman
                                                                             19:00 • 21:30
                                   of the City of Amsterdam

    Getting to 90: Addressing      ECDC and the European AIDS
                                                                                             12:30 • 14:30
    Inequalities in the HIV        Clinical Society (EACS)
                                                                                               Emerald
    Continuum of Care in                                                                        Room
    Europe and Central Asia
    Ministerial policy dialogue    WHO Euro and the Ministry
    on HIV and related             of Foreign Affairs of
    comorbidities in eastern       the Netherlands                                           14:00 • 17:30
    Europe and central Asia
    (EECA)
    Harm reduction for people HA-REACT, Chafea, SANTE and
    who inject drugs in Europe: EMCDDA                                                       14:45 • 16:45
    findings from European                                                                      Hall 10
    Joint Action HA-REACT
    European Surveys and           ESTICOM, Chafea, SANTE and
    Trainings to Improve           ECDC                                                      17:00 • 19:00
    MSM Community Health                                                                      Auditorium
    (ESTICOM)
    ‘Leadership Workshop’       Public Health England,
    on ‘Eliminating HIV         the European AIDS Treatment
    transmission is now         Group and ECDC                                                               11:00 • 12:30
    a reality for gay men: What                                                                                Atrium 2
    has worked and how do                                                                                       (L002)
    we replicate our successes
    for all?’
    Implementing the SDG     UNAIDS, IAS, EC
    Agenda to leave no one                                                                                   14:30 • 16:00
    behind – Innovations in                                                                                     Hall 12
    Europe on the Fast Track
    to Ending AIDS symposium
    HIV Outcomes workshop          HIV Outcomes initiative, EC
    on improving long-term                                                                                   18:30 • 20:00
    chronic care for people
    living with HIV (PLHIV)
    HIV and co-infections in       INTEGRATE, Chafea, SANTE
    vulnerable populations:        and ECDC
    Addressing cross-border
    treatment needs and                                                                                                      18:30 • 20:30
    ensuring earlier diagnosis                                                                                                  Forum
    of migrants, homeless,
    prisoners and other
    vulnerable populations
     with co- infections
E U C O N T R I B U T I O N T O H I V , V I R A L H E PAT I T I S A N D T U B E R C U LO S I S P R E V E N T I O N A N D I N T E G R AT E D R E S P O N S E                 3

                                                                                                                                                                                                       2 3 - 2 7 J U LY 2 0 1 8 ● A M S T E R D A M ● T H E N E T H E R L A N D S
                (HA-REACT): EU HEALTH PROGRAMME 2014-2020
                HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS IN EUROPE:
                FINDINGS FROM EUROPEAN JOINT ACTION
                MONDAY 23 JULY 2018 ● 14:45 • 16:45 ● HALL 10
      CHAIR     Mika Salminen, National Institute for Health and Welfare, Finland
  CO-CHAIR      Jean Luc Sion, European Commission, DG SANTE, Luxembourg
FACILITATOR     Sini Pasanen, Civil Society Forum on HIV/AIDS, Hepatitis and Tuberculosis, Finland

14:45 • 14:55   Opening of the Satellite
                Mika Salminen, National Institute for Health and Welfare, Finland
                Jean Luc Sion, European Commission, DG SANTE, Luxembourg

14:55 • 15:05   EU Policy framework, presenting the Staff Working Document 2018
                Jean Luc Sion, European Commission, DG SANTE, Luxembourg

15:05 • 15:15   HIV/HCV testing within low-threshold services for women who use drugs –
                barriers and recommendations
                Alexandra Gurinova, Deutsche AIDS-Hilfe (DAH), Germany

15:15 • 15:25   Harm reduction services in prisons: gaps, challenges and good practice examples
                Heino Stöver, Frankfurt University of Applied Sciences (ISFF), Germany

15:25 • 15:35   Harm reduction services in Europe, Mobile unit service for PWID in Latvia
                Luis Sordo Del Castillo, Biomedical Research Networking Centre (CIBER/ISCIII), Spain

15:35 • 15:45   Access barriers and good practices to promote prevention and treatment services for PWID
                Jeffrey V. Lazarus, Centre of Excellence for Health, Immunity and Infections (CHIP/REGIONH), Denmark

15:45 • 15:55   Guidance on prevention and control of blood-borne viruses in prison settings
                Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal

15:55 • 16:45   Round table discussion: What are the challenges for preventing HIV and co-infections
                among PWID, what have we learnt from HA‑REACT and other EU actions, and how can
                we respond to these challenges? What does integration of services for PWID mean?

  PANELISTS     J oint Action on integrating prevention, testing and linkage to care strategies across HIV,
      FROM       viral hepatitis, TB and STIs in Europe (INTEGRATE)
                 Dorthe Raben, Centre of Excellence for Health, Immunity and Infections (CHIP/REGIONH), Denmark
                Early diagnosis and treatment of viral hepatitis (HepCare Europe)
                John S. Lambert, UCD/ Mater Misericordiae University Hospital, Ireland

                 arly detection and integrated management of tuberculosis in Europe (E-DETECT TB)
                E
                Gerard De Vries, KNCV Tuberculosefonds, Netherlands

                European Joint Action on HIV and Co-infection Prevention and Harm Reduction
                (HA-REACT)
                Aljona Kurbatova, National Institute for Health Development, Estonia

                European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
                Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction
4

                    ESTICOM: EUROPEAN SURVEYS AND TRAINING
                    TO IMPROVE MSM COMMUNITY HEALTH
                    MONDAY 23 JULY 2018 ● 17:00 • 19:00 ● AUDITORIUM

          CHAIR     Ulrich Marcus, Robert Koch Institute (RKI), Germany
       CO-CHAIR     Koen Block, European AIDS Treatment Group (EATG), Belgium

    17:00 • 17:08   EU Policy framework, presenting the Staff Working Document 2018
                    Jean Luc Sion, European Commission, DG SANTE, Luxembourg

    17:08 • 17:16   Overview of STI/HIV among MSM in the EU/EEA
                    Teymur Noori, European Centre for Disease Prevention and Control (ECDC), Sweden

    17:16 • 17:24   Drug use among MSM (brief overview with focus on chemsex)
                    Isabelle Giraudon, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal

    17:24 • 17:59   EMIS pan-European MSM survey, Background and overview of study (design, aims and
                    objectives) – who took part? Focus of the selected results will be on pre-exposure prophylaxis
                    and chemsex:
                    a. Distribution of risk and precautionary behaviors
                    b. Distribution of health promotion needs
                    c. Prevention intervention performance
                    d. Sexual morbidities
                    Axel J. Schmidt, Sigma Research at London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
                    Peter Weatherburn, Sigma Research at LSHTM, United Kingdom

    17:59 • 18:09   Moderated Q&A session

    18:09 • 18:29   ECHOES pan-European MSM Community Health Worker survey
                    a. Background and overview of study (design, aims and objectives) – who took part?
                    b. Types of CHW work performed (activities and settings)
                    c. Motivations and satisfaction about their role as CHW
                    d. Training received and training needs
                    Nicolas Lorente, Center for Epidemiological Studies on HIV/AIDS in Catalonia (CEEISCAT), Spain

    18:29 • 18:39   Training Programme: Overview of the Training Programme
                    Barrie Dwyer, Terrence Higgins Trust (THT), United Kingdom

    18:39 • 18:49   Initial findings of the Training Programme
                    a. Training needs of CHWs
                    b. B
                        arriers and facilitating factors to performing work as a CHW Experiences and lessons learned from
                       the Training Programme implementation
                    Matthias Kuske, Deutsche AIDS-Hilfe (DAH), Germany

    18:49 • 18:59   Moderated Q&A session
E U C O N T R I B U T I O N T O H I V , V I R A L H E PAT I T I S A N D T U B E R C U LO S I S P R E V E N T I O N A N D I N T E G R AT E D R E S P O N S E                 5

                                                                                                                                                                                                      2 3 - 2 7 J U LY 2 0 1 8 ● A M S T E R D A M ● T H E N E T H E R L A N D S
                INTEGRATE: HIV AND CO-INFECTIONS IN AT-RISK POPULATIONS: ADDRESSING
                CROSS-BORDER TREATMENT NEEDS AND ENSURING EARLIER DIAGNOSIS OF
                MIGRANTS, HOMELESS, PRISONERS AND OTHER VULNERABLE POPULATIONS
                WITH CO-INFECTIONS
                WEDNESDAY 25 JULY 2018 ● 18:30 • 20:30 ● FORUM
     CHAIRS     John S. Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
                Lella Cosmaro, Fondazione Lila Milano Onlus, Italy
                Jürgen Rockstroh, University of Bonn, Germany
                Daniel Simoes, Grupo de Ativistas em Tratamentos – GAT, Portugal

18:30 • 18:34   Welcome and introduction to the INTEGRATE Joint Action
                John S. Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
                Lella Cosmaro, Fondazione Lila Milano Onlus, Italy

18:34 • 18:41   EU Policy framework, presenting the Staff Working Document 2018
                Jean Luc Sion, European Commission, DG SANTE, Luxembourg

18:41 • 18:48   Monitoring the continuum of care and testing in Europe
                Andrew Amato, European Centre for Disease Prevention and Control, Sweden

18:48 • 18:55   Bridging to Eastern Europe and Central Asian countries – opportunities and challenges
                Elena Vovc, WHO Regional Office for Europe, Denmark

                Session 1: Integrated testing approaches – lessons learned and transferability
                across diseases and borders
18:55 • 19:05    .1. HepCare: Lessons learned on HCV testing and treatment among key risk groups, including drug users
                1
                and homeless, through outreach to the community and integration of primary and secondary care services
                John S Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland

19:05 • 19:15    .2 E-DETECT TB: Find and treat models in The Netherlands and UK, transferability to Eastern Europe
                1
                (Romania and Bulgaria) and options for integrated care delivery
                Gerard de Vries, KNCV Tuberculosis Foundation, Netherlands

19:15 • 19:30   1.3. Questions from the audience and discussion

                Session 2: Round table discussion: Risk groups and co-infections:
                prevention, linkage to care, and shared care models for care
                Jürgen Rockstroh, University of Bonn, Germany
                Daniel Simoes, Grupo de Ativistas em Tratamentos – GAT, Portugal

19:30 • 19:45    .1 Short introductory remarks by INTEGRATE partners on:
                2
                • Transferability of tools on testing and linkage to care across diseases – challenges and opportunities
                • How to use data in the implementation of programmes
                Dorthe Raben, Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, Denmark
                Ann Sullivan, Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom
                Jordi Casabona, Center for Epidemiological Studies on HIV/AIDS in Catalonia (CEEISCAT), Spain
                Valerie Delpech, Public Health England (PHE), United Kingdom

19:45 • 20:20    .2 Moderated discussion with panel and audience
                2
                PANEL MEMBERS
                John S. Lambert, Lella Cosmaro, Jean Luc Sion, Andrew Amato, Elena Vovc,
                Gerard de Vries, Dorthe Raben, Ann Sullivan, Jordi Casabona, Valerie Delpech

20:20 • 20:30    .3 Conclusions and next steps
                2
                CHAIRS
                John S. Lambert (Mater Misericordiae University Hospital and University College Dublin, Ireland)
                Lella Cosmaro (Fondazione Lila Milano Onlus, Italy)
6

    EXHIBITORS ● STAND 204 – 1
    European Commission: Directorate General for Health and Food Safety (DG SANTE); Directorate-General for Research and
    Innovation (DG RTD; Consumer, Health and Food Executive Agency (Chafea); European Centre for Disease Prevention and Control
    (ECDC); European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
    Partners: Health Programme EU networks, HA‑REACT Joint Action; INTEGRATE Joint Action; ESTICOM contract; HEPCARE EUROPE
    project; E-DETECT TB project; AIDS Action Europe (AAE); TB Europe Coalition (TBEC) and Correlation network

    MEET AND GREET ● STAND 204 – 2
                    24 JULY                          25 JULY                            26 JULY                           27 JULY
    10:00 • 10:30   ECDC/EMCDDA                      OptTEST                                                              ESTICOM
                    Launch of new ECDC/EMCDDA        Legal and regulatory barriers                                        Comunity Health Worker
                    public health guidance           work: Stigma and legal/                                              training programme
                    ‘Prevention and control of       regulatory barriers to provision
                    blood-borne viruses in prison    and uptake of HIV testing
                    settings’                        & treatment services
    10:45 • 11:15   OptTEST                          OptTEST                            EDCTP                             ESTICOM
                    How to increase HIV testing:     Legal and regulatory barriers      European & Developing             Launch of the EMIS/ECHOES
                    Presentation of tools            work: Stigma and legal/            Countries Clinical Trials         community project
                    developed to optimise HIV        regulatory barriers to provision   Partnership (EDCTP) - Beyond
                    testing and linkage to care      and uptake of HIV testing          the trial: an equitable
                                                     & treatment services               environment for research
    11:30 • 12:00   EMCDDA                           TBEC
                    The current landscape of         Meet TB Europe Coalition!
                    opioid overdoses and harm
    12:15 • 12:45   reduction strategies in Europe   ESTICOM                            ECDC
                    (presentation)                   Launch of the EMIS/ECHOES          The ECDC HIV Estimates
                                                     community reports                  Accuracy Tool is coming
                                                                                        soon: take a sneak peek at it
    13:00 • 13:30   OptTEST                          INTEGRATE                          during AIDS 2018 to calculate     ESTICOM
                    How to increase HIV testing:     The new results of PARTNER         adjusted estimates from case-     EMIS results on the topics
                    Presentation of tools            II on condomless anal sex in       based HIV surveillance data       PrEP and Chemsex
                    developed to optimise HIV        MSM sero‑discordant couples        taking into account the issues
                    testing and linkage to care      What are the implications for      of missing data and reporting
                                                     the treatment as prevention        delay. (12:15 • 13:15)
                                                     approach and U=U?
    13:45 • 14:15   ECDC                                                                ECDC                            ESTICOM
                    Towards 90-90-90: learn how                                         The ECDC HIV Estimates          EMIS results on the topics
                    to use ECDC’s HIV modelling                                         Accuracy Tool is coming soon:   PrEP and Chemsex
                    tool to estimate national or                                        take a sneak peek at it during
                    local HIV incidence in our                                          AIDS 2018 to calculate adjusted
                    ‘drop-in’ training                                                  estimates from case-based HIV
                    (13:45 • 14:45)                                                     surveillance data taking into
                                                                                        account the issues of missing
                                                                                        data and reporting delay.
                                                                                        (13:30 • 14:30)

    14:30 • 15:00                                    TBEC
                                                     Meet TB Europe Coalition!
    15:15 • 15:45   HEPCARE EUROPE                   INTEGRATE                          AAE
                    Utilizing a mobile health        Reaching key populations in        AAE network video: Access
                    unit to reach vulnerable         need of HIV and viral hepatitis    to health services for migrants
                    populations                      testing and prompt linkage         with irregular status
                                                     to care through European
    16:00 • 16:30   HEPCARE EUROPE                   Testing Week                       AAE
                    Utilizing a mobile health                                           AAE network video: Access
                    unit to reach vulnerable                                            to health services for migrants
                    populations                                                         with irregular status
    16:45 • 17:15   ECDC                             ESTICOM                            ESTICOM
                    Towards 90-90-90: learn how      EMIS results on the topics         EMIS results on the topics
                    to use ECDC’s HIV modelling      PrEP and Chemsex                   PrEP and Chemsex
                    tool to estimate national or
                    local HIV incidence in our
                    ‘drop‑in’ training
    17:30 • 18:00   HEPCARE EUROPE                   ESTICOM                            ESTICOM
                    Utilizing a mobile               Comunity Health Worker             EMIS results on the topics
                    health unit to reach             training programme                 PrEP and Chemsex
                    vulnerable populations
E U C O N T R I B U T I O N T O H I V , V I R A L H E PAT I T I S A N D T U B E R C U LO S I S P R E V E N T I O N A N D I N T E G R AT E D R E S P O N S E                 7

                                                                                                                                                                                                         2 3 - 2 7 J U LY 2 0 1 8 ● A M S T E R D A M ● T H E N E T H E R L A N D S
EXHIBITION ● STAND 204 – 3
24 JULY                           25 JULY                                            26 JULY                                                  27 JULY
10:00 • 14:00                    10:00 • 12:30                                      10:00 • 14:00                                            10:00 • 12:00
HEPCARE                          INTEGRATE MATERIALS                                RTD                                                      HA REACT
14:30 • 18:30                    13:00 • 15:30                                      14:30 • 18:30
ECDC                             E-DETECT TB                                        ECDC
                                 16:30 • 18:30
                                 EDCTP

GLOBAL VILLAGE ● 23 TO 27 JULY 2018
AIDS Action Europe (AAE) will be implementing in collaboration with the European AIDS Treatment group (EATG) an NGO booth
in the Global Village with a special focus on GO and NGO collaboration in the WHO European region

TB coalition (TBEC) will present two presentations at AIDS Action Europe booth:
TBEC introduction to the network, with specific focus on commonalities: HIV/TB co-infection, transition and integrated health systems
One on transition and sustainability (presenting case studies on Estonia, Bulgaria and Georgia)
Transitioning from donor support for TB and HIV in Eastern Europe: civil society response, Rachael Hore, TBEC/Results UK (UK),
with participation of TBEC members

Correlation network: Harm Reduction Networking Zone

23 July                    24 July                            25 July                                       26 July                                      27 July

The Dutch Drug Policy      International Drug                New HR challenges                             Specific target groups                        Drug User Organisation
                           Policy and the need for           (NPS, Stimulant Use,                          (Women, Prisoners,                            and peer involvement
                           funding                           Chemsex,...)                                  Migrants, MSM,...)                            (throughout the whole
                                                                                                                                                         programme and Friday)

Drug Consumption
Rooms

New prison guidance at UN/NL-oganised ‘Prison Corner’ inside Harm Reduction Networking Zone, by ECDC/EMCDDA:
Speakers: Anastasia Pharris (ECDC) & Dagmar Hedrich (EMCDDA)

90-minute Panel Discussion with international experts: ‘Connecting the Dots: Stop Overdose Now!’
who will address ‘Global Epidemiology of HIV, HCV, TB and Opioid Overdose: Unrelated Events or Expanded Syndemic?’,
by Stop Overdose Now Foundation (NL) and EMCDDA, speaker Isabelle Giraudon
8

    When you would like to follow
    the European commission activities,
    the satellite symposium will take place
    in venue: Venue: Hall 10, Auditorium
    and Forum

    The EC stand exhibition location is 204.

    ✚                                                FIND OUT MORE
                      Directorate-General for Health and Food Safety of the European Commission (DG SANTE)
                       https://ec.europa.eu/health/communicable_diseases/sexually_transmitted_infections_en
                                    European Centre for Disease Prevention and Control (ECDC)
                                          https://ecdc.europa.eu/en/hiv-infection-and-aids
                                European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
                      http://www.emcdda.europa.eu/news/2018/ecdc-emcdda-communicable-diseases-prison_en
                                  Consumer, Health, Agriculture and Food Safety Agency (Chafea)
                                     https://webgate.ec.europa.eu/chafea_pdb/health/projects/
You can also read